Agilis Biotherapeutics

Provider of gene therapy platform for rare monogenic diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2013 groups14 employees language agilisbio.com

Registered entities

Investor mix

2 investors on record; lead investors include Sands Capital Ventures.

Investor typeCountShare
Venture capital2100%
Coming soon